|
Real-time Estimate
Cboe BZX
12:27:45 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 94.13 USD | +0.67% |
|
-5.12% | +18.51% |
| 05:55am | JPMorgan Adjusts Price Target on CVS Health to $118 From $111, Keeps Overweight Rating | MT |
| 08-07 | DA Davidson Adjusts Price Target on CVS Health to $120 From $100, Maintains Buy Rating | MT |
| Market Cap | 120B 104B 97.07B 88.54B 166B 11,406B 169B 1,142B 446B 5,711B 449B 439B 19,043B | P/E 2026 * |
13.8x | P/E 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise Value | 171B 149B 139B 127B 239B 16,357B 242B 1,637B 640B 8,190B 644B 630B 27,311B | EV / Sales 2026 * |
0.41x | EV / Sales 2027 * | 0.39x |
| Free-Float |
71.17% | Yield 2026 * |
2.84% | Yield 2027 * | 2.93% |
Last Transcript: CVS Health Corporation
| 1 day | +0.66% | ||
| 1 week | -5.12% | ||
| Current month | -9.94% | ||
| 1 month | -11.19% | ||
| 3 months | -1.16% | ||
| 6 months | +20.68% | ||
| Current year | +18.51% |
| 1 week | 93.01 |  | 101 |
| 1 month | 93.01 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 65.26 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.67% | -5.12% | +43.56% | +26.51% | 120B | |
| -0.19% | +0.22% | +5.18% | +51.55% | 89.08B | |
| -0.70% | +0.36% | +6.02% | +56.75% | 30.64B | |
| +0.18% | +1.02% | +33.34% | +76.27% | 26.21B | |
| -0.17% | -2.80% | -10.00% | -12.90% | 21.68B | |
| +1.72% | +0.71% | +54.62% | +260.06% | 20.89B | |
| -2.38% | -5.98% | -12.48% | +4.86% | 14.14B | |
| -1.91% | -0.73% | -0.80% | -9.17% | 12.79B | |
| +0.46% | -5.03% | +35.67% | +67.53% | 11.37B | |
| -3.08% | -5.71% | -20.19% | +90.51% | 10.61B | |
| Average | -0.53% | -2.73% | +13.49% | +61.20% | 35.7B | |
| Weighted average by Cap. | -0.01% | -3.08% | +21.45% | +51.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 418B 362B 339B 309B 581B 39,842B 590B 3,988B 1,559B 19,950B 1,568B 1,534B 66,521B | 430B 372B 349B 318B 598B 40,978B 607B 4,102B 1,603B 20,518B 1,613B 1,578B 68,417B |
| Net income | 8.8B 7.62B 7.14B 6.51B 12.25B 839B 12.44B 84.01B 32.84B 420B 33.04B 32.32B 1,401B | 9.1B 7.89B 7.39B 6.74B 12.67B 868B 12.87B 86.92B 33.98B 435B 34.18B 33.44B 1,450B |
| Net Debt | 51.92B 44.98B 42.14B 38.44B 72.27B 4,952B 73.38B 496B 194B 2,479B 195B 191B 8,267B | 49.15B 42.58B 39.9B 36.39B 68.41B 4,688B 69.46B 469B 183B 2,347B 185B 181B 7,826B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | US$94.08 | +0.62% | 1,710,402 |
| 26-08-11 | US$93.50 | -2.27% | 8,122,813 |
| 26-08-10 | US$95.67 | -0.03% | 7,025,233 |
| 26-08-07 | US$95.70 | -0.54% | 12,403,394 |
| 26-08-06 | US$96.22 | -2.93% | 10,583,035 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
